Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

(MIGA) Mini Geriatric Assessment To Replace the Comprehensive Geriatric Assessment (MIGA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01318759
Recruitment Status : Unknown
Verified March 2011 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
First Posted : March 18, 2011
Last Update Posted : March 18, 2011
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center

Tracking Information
First Submitted Date March 17, 2011
First Posted Date March 18, 2011
Last Update Posted Date March 18, 2011
Study Start Date March 2011
Estimated Primary Completion Date March 2014   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title (MIGA) Mini Geriatric Assessment To Replace the Comprehensive Geriatric Assessment
Official Title (MIGA) Mini Geriatric Assessment as Compared to the Current CGA
Brief Summary

This is a comprehensive Geriatric Assessment (CGA) currently used to evaluate elderly people in order to be able to assess their multiple organ pathology, cognitive, functional and social problems. This CGA is a very time consuming tool although a powerful one.

The investigators want to present a new assessment test witch is short and comprehensive tool witch will be checked in ambulatory and in-hospital geriatric patients.

Detailed Description

MIGA test (Mini Geriatric Assessment) includes the following parameters Walking outdoors, Transfer, ADL-Dressing, Washing, Continence, Vision, Hearing, Pain, Sleeping, Weight loss, Get-Up-And-Go test, Short term memory, Clock drawing test, Falls, functional reach of hands, Depression, Behavioral problems, social support, Admissions, Polypharmacy,

All patients will be assessed by the traditional CGA and by the new MIGA test. Time consuming of the two tests will be measured and compared.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population people aged over 65
Condition Geriatric Disorder
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: March¬†17,¬†2011)
400
Original Estimated Enrollment Same as current
Estimated Study Completion Date March 2014
Estimated Primary Completion Date March 2014   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Elderly people age 65 and above,
  • In patients hospitalized in the geriatric department
  • Out patients -from the geriatric out patient clinic
  • Elderly patients visiting in the emergency room

Exclusion criteria:

  • People under 65 years old
  • Critically ill patients ( acute infection, acute myocardial infarction, hypoxia, hemodynamic instability)
Sex/Gender
Sexes Eligible for Study: All
Ages 65 Years and older   (Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Israel
Removed Location Countries  
 
Administrative Information
NCT Number NCT01318759
Other Study ID Numbers 0047-11-tav
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Yaffa Lerman MD, Tel-Aviv Sourasky Medical Center
Study Sponsor Tel-Aviv Sourasky Medical Center
Collaborators Not Provided
Investigators
Study Director: Yaffa Lerman, MD Tel-Aviv Sourasky Medical Center
Principal Investigator: Oksana Borodin, MD Tel-Aviv Sourasky Medical Center
PRS Account Tel-Aviv Sourasky Medical Center
Verification Date March 2011